Published in BMC Infect Dis on June 01, 2009
Evidence assessments and guideline recommendations in Lyme disease: the clinical management of known tick bites, erythema migrans rashes and persistent disease. Expert Rev Anti Infect Ther (2014) 1.48
Retracted Detection and differentiation of Borrelia burgdorferi sensu lato in ticks collected from sheep and cattle in China. BMC Vet Res (2011) 1.17
Severity of chronic Lyme disease compared to other chronic conditions: a quality of life survey. PeerJ (2014) 0.89
Probable late lyme disease: a variant manifestation of untreated Borrelia burgdorferi infection. BMC Infect Dis (2012) 0.88
Serum inflammatory mediators as markers of human Lyme disease activity. PLoS One (2014) 0.87
Simple objective detection of human lyme disease infection using immuno-PCR and a single recombinant hybrid antigen. Clin Vaccine Immunol (2014) 0.87
Early Lyme disease with spirochetemia - diagnosed by DNA sequencing. BMC Res Notes (2010) 0.85
Detection of borreliae in archived sera from patients with clinically suspect Lyme disease. Int J Mol Sci (2014) 0.84
An Enhanced ELISPOT Assay for Sensitive Detection of Antigen-Specific T Cell Responses to Borrelia burgdorferi. Cells (2013) 0.83
DNA sequencing diagnosis of off-season spirochetemia with low bacterial density in Borrelia burgdorferi and Borrelia miyamotoi infections. Int J Mol Sci (2014) 0.80
Development of a Multiantigen Panel for Improved Detection of Borrelia burgdorferi Infection in Early Lyme Disease. J Clin Microbiol (2015) 0.80
Pancytopenia in Lyme disease. BMJ Case Rep (2014) 0.78
Longitudinal Transcriptome Analysis Reveals a Sustained Differential Gene Expression Signature in Patients Treated for Acute Lyme Disease. MBio (2016) 0.78
Lyme disease and pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS): an overview. Int J Gen Med (2012) 0.78
Toll-like receptor cascade and gene polymorphism in host-pathogen interaction in Lyme disease. J Inflamm Res (2016) 0.76
Socio-Economic Characteristics in Notified Erythema Migrans Patients. Zdr Varst (2015) 0.75
The Potential of Omics Technologies in Lyme Disease Biomarker Discovery and Early Detection. Infect Dis Ther (2016) 0.75
A Review of the Centers for Disease Control and Prevention's Guidelines for the Clinical Laboratory Diagnosis of Lyme Disease. J Chiropr Med (2016) 0.75
Bull's-Eye and Nontarget Skin Lesions of Lyme Disease: An Internet Survey of Identification of Erythema Migrans. Dermatol Res Pract (2012) 0.75
Management of paediatric Lyme disease in non-endemic and endemic areas: data from the Registry of the Italian Society for Pediatric Infectious Diseases. Eur J Clin Microbiol Infect Dis (2012) 0.75
The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis (2006) 13.01
Case definitions for infectious conditions under public health surveillance. Centers for Disease Control and Prevention. MMWR Recomm Rep (1997) 10.41
Recommendations for test performance and interpretation from the Second National Conference on Serologic Diagnosis of Lyme Disease. MMWR Morb Mortal Wkly Rep (1995) 7.11
Vaccination against Lyme disease with recombinant Borrelia burgdorferi outer-surface lipoprotein A with adjuvant. Lyme Disease Vaccine Study Group. N Engl J Med (1998) 6.18
Surveillance for Lyme disease--United States, 1992-2006. MMWR Surveill Summ (2008) 4.77
Diagnosis of lyme borreliosis. Clin Microbiol Rev (2005) 4.48
Duration of antibiotic therapy for early Lyme disease. A randomized, double-blind, placebo-controlled trial. Ann Intern Med (2003) 3.96
Post-Lyme borreliosis syndrome: a meta-analysis of reported symptoms. Int J Epidemiol (2005) 3.32
Systemic symptoms without erythema migrans as the presenting picture of early Lyme disease. Am J Med (2003) 3.23
Practice parameter: treatment of nervous system Lyme disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology (2007) 3.12
Azithromycin compared with amoxicillin in the treatment of erythema migrans. A double-blind, randomized, controlled trial. Ann Intern Med (1996) 2.58
Evolution of the serologic response to Borrelia burgdorferi in treated patients with culture-confirmed erythema migrans. J Clin Microbiol (1996) 2.43
Does this patient have erythema migrans? JAMA (2007) 2.12
Lyme disease--United States, 2003-2005. MMWR Morb Mortal Wkly Rep (2007) 1.72
Musculoskeletal and neurologic outcomes in patients with previously treated Lyme disease. Ann Intern Med (1999) 1.68
Lyme disease masquerading as brown recluse spider bite. Ann Emerg Med (2002) 1.63
Long-term follow-up of patients with culture-confirmed Lyme disease. Am J Med (2003) 1.62
Clinical practice. Early Lyme disease. N Engl J Med (2006) 1.49
Chest pain in a military recruit. South Med J (2008) 1.45
The clinical spectrum of early Lyme borreliosis in patients with culture-confirmed erythema migrans. Am J Med (1996) 1.42
Underreporting of Lyme disease by Connecticut physicians, 1992. J Public Health Manag Pract (1996) 1.39
Two-year evaluation of Borrelia burgdorferi culture and supplemental tests for definitive diagnosis of Lyme disease. J Clin Microbiol (2005) 1.21
The public health impact of Lyme disease in Maryland. J Infect Dis (1996) 1.17
Lyme disease misdiagnosed as a brown recluse spider bite. Ann Intern Med (1987) 1.16
Failure of treatment with cephalexin for Lyme disease. Arch Fam Med (2000) 1.15
Lyme disease knowledge, beliefs, and practices of New Hampshire primary care physicians. J Am Board Fam Pract (2002) 1.12
Summary of the first 100 patients seen at a Lyme disease referral center. Am J Med (1990) 1.12
Evaluation of study patients with Lyme disease, 10-20-year follow-up. J Infect Dis (2000) 1.00
In vitro activities of fluoroquinolones against the spirochete Borrelia burgdorferi. Antimicrob Agents Chemother (2001) 0.99
Toward a more complete appreciation of the clinical spectrum of Borrelia burgdorferi infection: early Lyme disease without erythema migrans. Am J Med (2003) 0.97
Misdiagnosis of erythema migrans. Am J Med (1995) 0.96
Spinal cord involvement in the nonhuman primate model of Lyme disease. Lab Invest (2004) 0.96
Controlled trials of antibiotic treatment in patients with post-treatment chronic Lyme disease. Vector Borne Zoonotic Dis (2002) 0.95
The diagnosis of brown recluse spider bite is overused for dermonecrotic wounds of uncertain etiology. Ann Emerg Med (2002) 0.93
Response to meta-analysis of Lyme borreliosis symptoms. Int J Epidemiol (2005) 0.87
Tickborne infections as a cause of nonspecific febrile illness in Wisconsin. Clin Infect Dis (2001) 0.86
Laboratory aspects of tick-borne diseases: lyme, human granulocytic ehrlichiosis and babesiosis. Mt Sinai J Med (2003) 0.83
Lyme carditis: another diagnostically elusive spirochetal disease. South Med J (2008) 0.80
Is neuroborreliosis a medical emergency? Neurocrit Care (2006) 0.77
Mass treatment with single-dose azithromycin for trachoma. N Engl J Med (2004) 5.30
Strategies for control of trachoma: observational study with quantitative PCR. Lancet (2003) 3.40
Design and baseline data of a randomized trial to evaluate coverage and frequency of mass treatment with azithromycin: the Partnership for Rapid Elimination of Trachoma (PRET) in Tanzania and The Gambia. Ophthalmic Epidemiol (2011) 3.05
Polymorphisms in Chlamydia trachomatis tryptophan synthase genes differentiate between genital and ocular isolates. J Clin Invest (2003) 3.04
Falls and fear of falling: which comes first? A longitudinal prediction model suggests strategies for primary and secondary prevention. J Am Geriatr Soc (2002) 2.85
Field evaluation of a rapid point-of-care assay for targeting antibiotic treatment for trachoma control: a comparative study. Lancet (2006) 2.65
Infection with Chlamydia trachomatis after mass treatment of a trachoma hyperendemic community in Tanzania: a longitudinal study. Lancet (2005) 2.62
Re-emergence of Chlamydia trachomatis infection after mass antibiotic treatment of a trachoma-endemic Gambian community: a longitudinal study. Lancet (2005) 2.50
Driving status and risk of entry into long-term care in older adults. Am J Public Health (2006) 2.32
Which members of a community need antibiotics to control trachoma? Conjunctival Chlamydia trachomatis infection load in Gambian villages. Invest Ophthalmol Vis Sci (2003) 2.20
Gastrointestinal symptoms associated with orthostatic intolerance. J Pediatr Gastroenterol Nutr (2005) 2.10
Task-shifting HIV counselling and testing services in Zambia: the role of lay counsellors. Hum Resour Health (2009) 2.02
Impact of presbyopia on quality of life in a rural African setting. Ophthalmology (2006) 2.00
Evaluation of the National Eye Institute visual function questionnaire in Graves' ophthalmopathy. Ophthalmology (2006) 1.96
Mass treatment and the effect on the load of Chlamydia trachomatis infection in a trachoma-hyperendemic community. Invest Ophthalmol Vis Sci (2005) 1.94
The impact of visual impairment and eye disease on vision-related quality of life in a Mexican-American population: proyecto VER. Invest Ophthalmol Vis Sci (2002) 1.92
Blindness, visual impairment and the problem of uncorrected refractive error in a Mexican-American population: Proyecto VER. Invest Ophthalmol Vis Sci (2002) 1.86
The utility of "Google Trends" for epidemiological research: Lyme disease as an example. Geospat Health (2010) 1.82
Trachoma prevalence and associated risk factors in the gambia and Tanzania: baseline results of a cluster randomised controlled trial. PLoS Negl Trop Dis (2010) 1.81
Is there an association between cataract surgery and age-related macular degeneration? Data from three population-based studies. Am J Ophthalmol (2003) 1.80
Population-based study of presbyopia in rural Tanzania. Ophthalmology (2006) 1.72
Mass distribution of azithromycin for trachoma control is associated with increased risk of azithromycin-resistant Streptococcus pneumoniae carriage in young children 6 months after treatment. Clin Infect Dis (2013) 1.71
Association of visual field loss and mobility performance in older adults: Salisbury Eye Evaluation Study. Optom Vis Sci (2004) 1.69
Single-dose azithromycin prevents trichiasis recurrence following surgery: randomized trial in Ethiopia. Arch Ophthalmol (2006) 1.69
Factors associated with spectacle-wear compliance in school-aged Mexican children. Invest Ophthalmol Vis Sci (2006) 1.66
Risk factors for postsurgical trichiasis recurrence in a trachoma-endemic area. Invest Ophthalmol Vis Sci (2005) 1.62
A prospective, population-based study of the role of visual impairment in motor vehicle crashes among older drivers: the SEE study. Invest Ophthalmol Vis Sci (2007) 1.58
Glaucoma and mobility performance: the Salisbury Eye Evaluation Project. Ophthalmology (2007) 1.51
Estimating the rate of progressive visual field damage in those with open-angle glaucoma, from cross-sectional data. Invest Ophthalmol Vis Sci (2008) 1.47
Driving cessation and driving limitation in glaucoma: the Salisbury Eye Evaluation Project. Ophthalmology (2009) 1.47
Impact of dry eye on reading in a population-based sample of the elderly: the Salisbury Eye Evaluation. Br J Ophthalmol (2013) 1.45
Prospective association between hypotension and idiopathic chronic fatigue. J Hypertens (2004) 1.45
Definitions and standardization of a new grading scheme for eyelid contour abnormalities after trichiasis surgery. PLoS Negl Trop Dis (2012) 1.44
Trachoma and ocular Chlamydia trachomatis were not eliminated three years after two rounds of mass treatment in a trachoma hyperendemic village. Invest Ophthalmol Vis Sci (2007) 1.43
Causal inference for non-mortality outcomes in the presence of death. Biostatistics (2006) 1.42
Measures of visual function and their association with driving modification in older adults. Invest Ophthalmol Vis Sci (2006) 1.40
CT694 and pgp3 as serological tools for monitoring trachoma programs. PLoS Negl Trop Dis (2012) 1.40
Sensitivity, specificity, predictive values, and likelihood ratios. Pediatr Rev (2010) 1.39
Risk factors for Type II diabetes and diabetic retinopathy in a mexican-american population: Proyecto VER. Am J Ophthalmol (2002) 1.39
Measures of visual function and time to driving cessation in older adults. Optom Vis Sci (2005) 1.38
The prevalence of open-angle glaucoma among blacks and whites 73 years and older: the Salisbury Eye Evaluation Glaucoma Study. Arch Ophthalmol (2006) 1.37
The Global Trachoma Mapping Project: Methodology of a 34-Country Population-Based Study. Ophthalmic Epidemiol (2015) 1.36
Glaucoma and quality of life: the Salisbury Eye Evaluation. Ophthalmology (2007) 1.35
Embolotherapy for pelvic congestion syndrome: long-term results. J Vasc Interv Radiol (2006) 1.33
Community risk factors for ocular Chlamydia infection in Niger: pre-treatment results from a cluster-randomized trachoma trial. PLoS Negl Trop Dis (2012) 1.33
Number of years of annual mass treatment with azithromycin needed to control trachoma in hyper-endemic communities in Tanzania. J Infect Dis (2011) 1.32
The prevalence of primary angle closure glaucoma in European derived populations: a systematic review. Br J Ophthalmol (2012) 1.30
Contribution of sex-linked biology and gender roles to disparities with trachoma. Emerg Infect Dis (2004) 1.29
Community perspectives of childhood behavioral problems and ADHD among African American parents. Ambul Pediatr (2007) 1.26
Racial differences in the prevalence of age-related macular degeneration: the Salisbury Eye Evaluation (SEE) Project. Arch Ophthalmol (2008) 1.25
Spatial clustering of ocular chlamydial infection over time following treatment, among households in a village in Tanzania. Invest Ophthalmol Vis Sci (2006) 1.24
Development of a new platform for neglected tropical disease surveillance. Int J Parasitol (2012) 1.23
Glaucoma and reading speed: the Salisbury Eye Evaluation project. Arch Ophthalmol (2009) 1.21
Intensive insecticide spraying for fly control after mass antibiotic treatment for trachoma in a hyperendemic setting: a randomised trial. Lancet (2006) 1.20
Surgery for Trichiasis, Antibiotics to prevent Recurrence (STAR) Clinical Trial methodology. Ophthalmic Epidemiol (2005) 1.19
Causes of blindness and visual impairment in a population-based sample of U.S. Hispanics. Ophthalmology (2002) 1.19
Can clinical signs of trachoma be used after multiple rounds of mass antibiotic treatment to indicate infection? Invest Ophthalmol Vis Sci (2011) 1.18
A randomized, clinical trial evaluating ready-made and custom spectacles delivered via a school-based screening program in China. Ophthalmology (2009) 1.18
Risk of vision loss in patients with cytomegalovirus retinitis and the acquired immunodeficiency syndrome. Arch Ophthalmol (2003) 1.18
Risk factors for ocular infection with Chlamydia trachomatis in children 6 months following mass treatment in Tanzania. PLoS Negl Trop Dis (2011) 1.18
Knowledge of diabetic eye disease and vision care guidelines among Hispanic individuals in Baltimore with and without diabetes. Arch Ophthalmol (2008) 1.17
Prevalence of age-related macular degeneration in a population-based sample of Hispanic people in Arizona: Proyecto VER. Arch Ophthalmol (2005) 1.16
Cognitive and vision loss affects the topography of the attentional visual field. Invest Ophthalmol Vis Sci (2008) 1.16
Pelvic congestion syndrome (pelvic venous incompetence): impact of ovarian and internal iliac vein embolotherapy on menstrual cycle and chronic pelvic pain. J Vasc Interv Radiol (2002) 1.15
Mass treatment with azithromycin for trachoma: when is one round enough? Results from the PRET Trial in the Gambia. PLoS Negl Trop Dis (2013) 1.14
Visual acuity change and mortality in older adults. Invest Ophthalmol Vis Sci (2005) 1.13
Ethnic variation in AMD-associated complement factor H polymorphism p.Tyr402His. Hum Mutat (2006) 1.12
The impact of fish and shellfish consumption on age-related macular degeneration. Ophthalmology (2010) 1.11
Heritability of refractive error and familial aggregation of myopia in an elderly American population. Invest Ophthalmol Vis Sci (2005) 1.10
Mortality risk for patients with cytomegalovirus retinitis and acquired immune deficiency syndrome. Clin Infect Dis (2003) 1.09
Association of mass treatment with azithromycin in trachoma-endemic communities with short-term reduced risk of diarrhea in young children. Am J Trop Med Hyg (2011) 1.09
Relationship between immediate post-operative appearance and 6-week operative outcome in trichiasis surgery. PLoS Negl Trop Dis (2012) 1.09
Determinants and heritability of intraocular pressure and cup-to-disc ratio in a defined older population. Ophthalmology (2005) 1.08
Pattern of recurrence of trachomatous trichiasis after surgery surgical technique as an explanation. Ophthalmology (2005) 1.08
Presbyopia: prevalence, impact, and interventions. Community Eye Health (2007) 1.07
Issues in defining and measuring facial cleanliness for national trachoma control programs. Trans R Soc Trop Med Hyg (2008) 1.07
The relationship between better-eye and integrated visual field mean deviation and visual disability. Ophthalmology (2013) 1.07
Racial variations in causes of vision loss in nursing homes: The Salisbury Eye Evaluation in Nursing Home Groups (SEEING) Study. Arch Ophthalmol (2004) 1.07
Mass distribution of azithromycin for trachoma control is associated with short-term reduction in risk of acute lower respiratory infection in young children. Pediatr Infect Dis J (2012) 1.07
Visual field loss increases the risk of falls in older adults: the Salisbury eye evaluation. Invest Ophthalmol Vis Sci (2007) 1.06
Visual and cognitive deficits predict stopping or restricting driving: the Salisbury Eye Evaluation Driving Study (SEEDS). Invest Ophthalmol Vis Sci (2008) 1.04